NO303527B1 - Ïstrogenholdig medikament og anordning for transdermal administrering derav - Google Patents

Ïstrogenholdig medikament og anordning for transdermal administrering derav

Info

Publication number
NO303527B1
NO303527B1 NO931209A NO931209A NO303527B1 NO 303527 B1 NO303527 B1 NO 303527B1 NO 931209 A NO931209 A NO 931209A NO 931209 A NO931209 A NO 931209A NO 303527 B1 NO303527 B1 NO 303527B1
Authority
NO
Norway
Prior art keywords
estrogen
transdermal administration
administration device
containing drug
progesterone
Prior art date
Application number
NO931209A
Other languages
English (en)
Norwegian (no)
Other versions
NO931209D0 (no
NO931209L (no
Inventor
Robert M Gale
Diane E Nedberge
Linda E Atkinson
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of NO931209D0 publication Critical patent/NO931209D0/no
Publication of NO931209L publication Critical patent/NO931209L/no
Publication of NO303527B1 publication Critical patent/NO303527B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Semiconductor Lasers (AREA)
  • Vending Machines For Individual Products (AREA)
  • Steroid Compounds (AREA)
NO931209A 1990-10-29 1993-03-31 Ïstrogenholdig medikament og anordning for transdermal administrering derav NO303527B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/605,726 US5122382A (en) 1990-10-29 1990-10-29 Transdermal contraceptive formulations, methods and devices
PCT/US1991/007877 WO1992007589A1 (en) 1990-10-29 1991-10-25 Transdermal contraceptive formulations, methods and devices

Publications (3)

Publication Number Publication Date
NO931209D0 NO931209D0 (no) 1993-03-31
NO931209L NO931209L (no) 1993-04-26
NO303527B1 true NO303527B1 (no) 1998-07-27

Family

ID=24424948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931209A NO303527B1 (no) 1990-10-29 1993-03-31 Ïstrogenholdig medikament og anordning for transdermal administrering derav

Country Status (16)

Country Link
US (1) US5122382A (de)
EP (1) EP0577602B1 (de)
JP (1) JP2975684B2 (de)
AT (1) ATE171069T1 (de)
AU (1) AU9041991A (de)
CA (1) CA2088778C (de)
DE (1) DE69130232T2 (de)
DK (1) DK0577602T3 (de)
ES (1) ES2123547T3 (de)
IE (1) IE913741A1 (de)
MX (1) MX9101784A (de)
NO (1) NO303527B1 (de)
NZ (1) NZ240361A (de)
PT (1) PT99340B (de)
WO (1) WO1992007589A1 (de)
ZA (1) ZA918531B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5651973A (en) * 1990-06-01 1997-07-29 The Population Council Therapeutically effective topical application of ST1435
US5320850A (en) * 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
MX9303557A (es) * 1992-08-06 1994-03-31 Beta Pharm Co Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
EP0721349A1 (de) * 1993-09-29 1996-07-17 Alza Corporation Hautpermeabilitäterhöher für oxybutynin bestehend aus monoglycerid/laktat estern
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
AU726283B2 (en) * 1995-06-28 2000-11-02 Schering Aktiengesellschaft Pharmaceutical combined preparations, kit and method for hormonal contraception
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
FR2739032B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
WO1999032153A1 (en) * 1997-12-22 1999-07-01 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
US6699497B1 (en) * 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
HUP0104728A3 (en) * 1998-12-18 2006-07-28 Alza Corp Mountain View Transparent transdermal nicotine delivery device
US7384650B2 (en) 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
AU2003288699A1 (en) * 2002-12-30 2004-07-22 Given Imaging Ltd. Method for in vivo sensing
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
US8518926B2 (en) * 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
KR20090021169A (ko) * 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
CN101715443A (zh) 2007-03-14 2010-05-26 诺普神经科学股份有限公司 手性纯化的取代的苯并噻唑二胺的合成
WO2009009651A1 (en) * 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld
WO2009009649A1 (en) 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with in situ seal
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
CN102802418A (zh) * 2009-06-19 2012-11-28 诺普神经科学股份有限公司 用于治疗肌萎缩性侧索硬化的组合物和方法
KR101928321B1 (ko) 2009-12-17 2018-12-12 더 파퓰레이션 카운실 인코포레이티드 프로게스틴/에스트라디올 경피 젤
JP6527305B2 (ja) 2011-01-10 2019-06-05 インヴィオン， インコーポレイテッド 禁煙のためのβ−アドレナリン作動性インバースアゴニストの使用
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
WO2013177570A1 (en) 2012-05-25 2013-11-28 Terapio Corporation Methods of preventing or treating disease of the central nervous system using rlip76
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES3043076T3 (en) 2013-07-12 2025-11-24 Areteia Therapeutics Inc Treating elevated levels of eosinophils and/or basophils
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
EP3046544A4 (de) 2013-09-17 2017-03-22 Terapio Corporation Verfahren zur prävention oder behandlung von mucositis mit rlip76

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800038A (en) * 1972-04-21 1974-03-26 Biolog Concepts Inc Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag

Also Published As

Publication number Publication date
DE69130232D1 (de) 1998-10-22
DE69130232T2 (de) 1999-04-08
MX9101784A (es) 1992-06-05
ZA918531B (en) 1992-08-26
PT99340A (pt) 1992-09-30
NO931209D0 (no) 1993-03-31
CA2088778A1 (en) 1992-04-30
JPH06502429A (ja) 1994-03-17
ATE171069T1 (de) 1998-10-15
EP0577602A1 (de) 1994-01-12
ES2123547T3 (es) 1999-01-16
NO931209L (no) 1993-04-26
AU9041991A (en) 1992-05-26
DK0577602T3 (da) 1999-06-14
IE913741A1 (en) 1992-05-22
EP0577602B1 (de) 1998-09-16
PT99340B (pt) 1999-02-26
CA2088778C (en) 2001-08-14
JP2975684B2 (ja) 1999-11-10
US5122382A (en) 1992-06-16
WO1992007589A1 (en) 1992-05-14
NZ240361A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
DK0577602T3 (da) Transdermale antikonceptionelle formuleringer, fremgangsmåder og anordninger
FI950774A0 (fi) Valmiste käytettäväksi 3-ketodesogestreeliä sisältävään transdermaaliseen applikaatioon
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
FI903213A0 (fi) Foer transdermal administration avsett gestoden innehaollande medel.
DE3373866D1 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine
MD960330A (ro) Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament
FI914391A0 (fi) Sammansaettningar vilka foerstaerker hudens permeabilitet.
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
CY1109311T1 (el) Φαρμακευτικο σκευασμα το οποιο περιεχει εποθιλονη
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
DE69434121D1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
BR9908622A (pt) Composição farmacêutica à base de progesterona natural de sìntese e de estradiol, e seu processo de preparo
ZA951880B (en) Transdermal system in the form of a patch comprising a tamoxifen derivative
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
GR900100489A (el) Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες.
DE3860354D1 (de) Neigungseinstell- und verstellvorrichtung fuer klapp-, lehnstuehle und aehnliche gegenstaende.
IL93599A0 (en) Kit and/or composition for the prevention or treatment of aids
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ATE96235T1 (de) Filmherstellungverfahren und einstellvorrichtung dazu.
IT1243978B (it) Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma.
DK594789D0 (da) Farmaceutisk praeparat til systemisk, transdermal administration

Legal Events

Date Code Title Description
MK1K Patent expired